Page 31 - Global Pharmaceuticals & Biotech Stocks - Top Gainers Today

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Aug 25, 2025

Explore the Global Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.

3,050 companies

Company	Last Price	1D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
STRAP Strategic Partners	DKK 1,040.00	4.0%	8.3%	DKK 43.4m	n/a	PB2.3x	n/a	n/a
TCRX TScan Therapeutics	US$1.90	1.6%	-66.5%	US$106.1m	US$8.57	PS15.5x	E1.1%	n/a
PRLD Prelude Therapeutics	US$1.27	2.4%	-76.8%	US$70.2m	US$3.50	PS10.3x	E-3.8%	n/a
AGH Althea Group Holdings	AU$0.022	10.0%	15.8%	AU$16.9m	n/a	PB53.3x	n/a	n/a
TLPH Talphera	US$0.57	16.6%	-39.6%	US$10.1m	US$3.25	PS436.8x	E35.1%	n/a
GSD Devonian Health Group	CA$0.17	6.3%	6.3%	CA$26.2m	n/a	PB3.2x	n/a	n/a
DIABIO Diagonal Bio	SEK 0.008	14.3%	-70.0%	SEK 11.5m	n/a	PS9.7x	n/a	n/a
NMRA Neumora Therapeutics	US$1.63	0.6%	-86.1%	US$262.4m	US$6.05	PB1.4x	E19.8%	n/a
STTK Shattuck Labs	US$0.99	3.5%	-72.5%	US$46.0m	US$1.46	PS15.9x	E-17.3%	n/a
BCT BriaCell Therapeutics	CA$10.41	9.6%	-93.5%	CA$16.7m	n/a	PB1.1x	E13.3%	n/a
UNCY Unicycive Therapeutics	US$4.29	2.1%	17.5%	US$74.2m	US$63.13	PB4.6x	E46.9%	n/a
1J5 Hyphens Pharma International	S$0.32	1.6%	14.3%	S$98.8m	n/a	PE15.3x	E21.6%	4.7%
ATNM Actinium Pharmaceuticals	US$1.79	2.9%	-15.2%	US$54.3m	US$5.00	PB2.9x	E27.1%	n/a
RGIN Regenicin	US$0.0001	9,900.0%	n/a	US$15.3k	n/a	n/a	n/a	n/a
GX1 genXone	zł5.92	7.6%	-6.0%	zł19.6m	n/a	PS9.8x	n/a	0%
FF Fine Foods & Pharmaceuticals N.T.M	€8.82	0.7%	4.0%	€215.7m	€12.07	PE17.3x	E20.1%	1.6%
531541 Kobo Biotech	₹2.47	2.5%	-21.6%	₹58.8m	n/a	PE-1.2x	n/a	n/a
NOX Noxopharm	AU$0.11	4.8%	7.3%	AU$30.7m	n/a	PS13.7x	n/a	n/a
QTZM Quantumzyme	US$0.13	28.7%	n/a	US$5.1m	n/a	n/a	n/a	n/a
VXRT Vaxart	US$0.35	1.8%	-60.2%	US$80.7m	US$3.33	PB2.5x	E-10.0%	n/a
RVX Resverlogix	CA$0.10	5.3%	11.1%	CA$27.2m	n/a	PE-1.9x	n/a	n/a
OTLC Oncotelic Therapeutics	US$0.053	6.2%	160.0%	US$23.2m	n/a	PB2.8x	n/a	n/a
GDTC CytoMed Therapeutics	US$1.97	6.7%	36.0%	US$21.3m	n/a	PS58.2x	n/a	n/a
VBS Vectus Biosystems	AU$0.08	33.3%	-5.9%	AU$4.3m	n/a	PS4.8x	n/a	n/a

Page 31 of 128